Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs11220202 | chr11:125600333 | C/A | 0.0001 | 178 | 15.95 | 12.2 | 4.1 | KM Plot |
| PAAD | rs11220203 | chr11:125601511 | A/T | 0.0001 | 178 | 15.95 | 12.2 | 4.1 | KM Plot |
| PAAD | rs11220204 | chr11:125610058 | G/A | 0.0001 | 178 | 15.95 | 12.2 | 4.1 | KM Plot |
| PAAD | rs11220205 | chr11:125614360 | C/T | 0.0001 | 178 | 15.95 | 12.2 | 4.1 | KM Plot |
| PAAD | rs11220216 | chr11:125653914 | T/A | 5.8E-5 | 178 | 15.95 | 12.2 | 4.1 | KM Plot |
| PAAD | rs11220233 | chr11:125689965 | C/T | 6.44E-5 | 177 | 15.95 | 11.6 | 4.1 | KM Plot |
| PAAD | rs11220243 | chr11:125718730 | C/T | 0.000114 | 175 | 15.87 | 12.2 | 4.1 | KM Plot |
| PAAD | rs11220257 | chr11:125732990 | C/T | 0.000114 | 175 | 15.87 | 12.2 | 4.1 | KM Plot |
| PAAD | rs112228563 | chr15:78329979 | T/C | 0 | 177 | 15.48 | 17.78 | 1.03 | KM Plot |
| PAAD | rs112362262 | chr5:172101142 | CA/C | 9.32E-5 | 173 | 15.33 | 16.03 | 3.9 | KM Plot |
| PAAD | rs112379173 | chr19:5207292 | C/T | 8.38E-6 | 177 | 15.47 | 15.5 | 3.67 | KM Plot |
| PAAD | rs112386755 | chr8:72554666 | G/A | 6.92E-8 | 176 | 15.77 | 12.63 | 3.17 | KM Plot |
| PAAD | rs1124285 | chr16:3589846 | C/T | 3.48E-5 | 178 | 16.15 | 13.93 | 3.23 | KM Plot |
| PAAD | rs112431560 | chr21:44064958 | C/A | 1.47E-12 | 174 | 15.43 | 18.45 | 1.37 | KM Plot |
| PAAD | rs11245872 | chr11:50752748 | T/G | 0 | 175 | 15.48 | 15.4 | 0.35 | KM Plot |